Four-Year Disease-Free Remission in a Patient With POLE Mutation-Associated Colorectal Cancer Treated Using Anti-PD-1 Therapy.

Durando, Michael L; Menghani, Sanjay V; Baumann, Jessica L; Robles, Danny G; Day, Tovah A; Vaziri, Cyrus; Scott, Aaron J

Durando, Michael L; Menghani, Sanjay V; Baumann, Jessica L; Robles, Danny G; Day, Tovah A; Vaziri, Cyrus; Scott, Aaron J.

Afiliação

Durando ML; Banner-University Medical Center Tucson, Tucson, Arizona.
Menghani SV; Division of Hematology and Oncology, Department of Medicine.
Baumann JL; University of Arizona Cancer Center.
Robles DG; Department of Immunobiology, and.
Day TA; Department of Pathology, University of Arizona College of Medicine-Tucson, Tucson, Arizona.
Vaziri C; Now with Roche Tissue Diagnostics, Tucson, Arizona.
Scott AJ; Banner-University Medical Center Tucson, Tucson, Arizona.

J Natl Compr Canc Netw ; 20(3): 218-223, 2022 03.

Article em En | MEDLINE | ID: mdl-35276675

Assuntos

Neoplasias Colorretais; DNA Polimerase II; Adulto; Biomarcadores Tumorais; Neoplasias Colorretais/tratamento farmacológico; Neoplasias Colorretais/genética; Neoplasias Colorretais/patologia; DNA Polimerase II/genética; Humanos; Imunoterapia; Masculino; Mutação; Adulto Jovem

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / DNA Polimerase II Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google